Dimethyl Fumarate (Dimethyl Fumarate)
Overview of Dimethyl Fumarate
dimethyl fumarate which is also known by its chemical name, dimethyl (E) butenedioate, (C6H8O4). It is indicated for the treatment of patients with relapsing forms of multiple sclerosis
Indication of Dimethyl Fumarate
Dimethyl Fumarate is primarily indicated in conditions like Multiple sclerosis.
Contraindication of Dimethyl Fumarate
No data regarding the contra indications of Dimethyl Fumarate is available.
Side Effects of Dimethyl Fumarate
The symptomatic adverse reactions produced by Dimethyl Fumarate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Nausea, Diarrhea, Abdominal pain, Flushing.
Precautions of Dimethyl Fumarate
Dimethyl fumarate may cause lymphopenia. A recent CBC should be available before initiating treatment.A CBC is recommended annually, and as clinically indicated. Consider withholding treatment in patients with serious infections.Tecfidera has not been studied in patients with severe renal or severe hepatic impairment and caution should, therefore, be used in these patients. Tecfidera has not been studied in patients with severe active gastrointestinal disease and caution should, therefore, be used in these patients. Flushing